FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person * ESCARRA VICKI B (Last) (First) (Middle) C/O HEALTH NET, INC. 21650 OXNARD STREET (Street) WOODLAND HILLS CA 91367 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol HEALTH NET INC [ HNT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 09/29/2014
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/29/2014		S (1)		4,468	D	$ 45.69	17,852	D
Common Stock	09/29/2014		M (2)		11,600	A	$ 28.08	29,452	D
Common Stock	09/29/2014		S		9,500	D	$ 46.46 (3)	19,952	D
Common Stock	09/29/2014		S		2,100	D	$ 46.69 (4)	17,852	D
Common Stock	09/29/2014		M (5)		7,366	A	$ 15.30	25,218	D
Common Stock	09/29/2014		S		6,266	D	$ 46.47 (6)	18,952	D
Common Stock	09/29/2014		S		1,100	D	$ 46.7 (7)	17,852	D
Common Stock	09/29/2014		M (8)		12,859	A	$ 23.51	30,711	D
Common Stock	09/29/2014		S		8,928	D	$ 46.43 (9)	21,783	D
Common Stock	09/29/2014		S		3,931	D	$ 46.65 (10)	17,852	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$ 28.08	09/29/2014		M (2)			11,600	(11)	05/09/2018	Common Stock	11,600	$ 0	0	D
Stock Option (Right to Buy)	$ 15.30	09/29/2014		M (5)			7,366	(12)	05/22/2016	Common Stock	7,366	$ 0	0	D
Stock Option (Right to Buy)	$ 23.51	09/29/2014		M (8)			12,859	(13)	05/13/2017	Common Stock	12,859	$ 0	0	D

Explanation of Responses:

1. The sale of Common Stock by the Reporting Person, as reported on this Form 4, was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 (the "Act"), as amended.

2. Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 9, 2008 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2008 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2008 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.64 to $46.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.64 to $46.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

5. Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 22, 2009 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2009 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2009 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.66 to $46.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.67 to $46.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

8. Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2010 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2010 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2010 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.58 to $46.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.58 to $46.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

11. The 2008 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 9, 2008, the grant date.

12. The 2009 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 22, 2009, the grant date.

13. The 2010 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 13, 2010, the grant date.

	/s/ Vicki Escarra	10/01/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.